Opko Health OPK
NASDAQ OPK
$1.63 +0.03 (+1.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Opko Health's Depreciation & Amortization (CF) was $22.41 million in Q2 2026, down 2.7% from $23.03 million a year earlier but up 0.9% from the prior quarter.

Analysis

Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Opko Health's Depreciation & Amortization (CF) was $89.72 million through Jun 30, 2026, down 5.3% year-over-year; for FY2025, it came in at $91.63 million, down 6.7% from FY2024.

  • Depreciation & Amortization (CF) has now declined for three consecutive years, though with a five-year compound annual growth rate of 1.4% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $98.18 million in FY2024 (-6.8%), $105.3 million in FY2023 (-3.1%), $108.66 million in FY2022 (+38.0%) and $78.72 million in FY2021 (-7.8%).
  • Quarterly Depreciation & Amortization (CF) has moved between $18.96 million (Q3 2021) and $28 million (Q3 2022) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for 14 straight quarters, with an average decline of 6.2% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2022 (growth of 47.6%); the worst was Q3 2021 (a decline of 9.9%).
  • Per Business Quant data, OPK's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $22.2 million (Q1 2026), $22.37 million (Q4 2025) and $22.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 194.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 98.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.62 Bn
10 Opko Health 1.22 Bn -210.40 Mn 80.02 Mn 22.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.41 Mn
Mar 31, 2026 22.20 Mn
Dec 31, 2025 22.37 Mn
Sep 30, 2025 22.74 Mn
Jun 30, 2025 23.03 Mn
Mar 31, 2025 23.49 Mn
Dec 31, 2024 24.04 Mn
Sep 30, 2024 24.16 Mn
Jun 30, 2024 24.16 Mn
Mar 31, 2024 25.82 Mn
Dec 31, 2023 25.98 Mn
Sep 30, 2023 26.18 Mn
Jun 30, 2023 26.39 Mn
Mar 31, 2023 26.45 Mn
Dec 31, 2022 26.46 Mn
Sep 30, 2022 28.00 Mn
Jun 30, 2022 28.00 Mn
Mar 31, 2022 27.81 Mn
Dec 31, 2021 19.19 Mn
Sep 30, 2021 18.96 Mn
API Access

Opko Health Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OPK&period=max&api_key=YOUR_API_KEY